Atherectomy Devices Market (2026 - 2033)

Atherectomy Devices Market Summary

The global atherectomy devices market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 1.9 billion by 2033, at a CAGR of 7.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of around 40.0% in 2025. The increasing prevalence of target vascular diseases, including coronary artery disease (CAD) and peripheral artery disease (PAD), coupled with the growing emphasis on developing advanced minimally invasive treatment options, is expected to drive growth in the atherectomy devices market.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The rising global burden of target vascular diseases is primarily associated with population aging, sedentary lifestyles, obesity, and other cardiovascular risk factors. According to the National Center for Biotechnology Information (NCBI), PAD affects more than 230 million people worldwide, with prevalence particularly high among older adults. This growing disease burden is expected to increase demand for effective vascular treatment and atherectomy devices.

The demand for minimally invasive surgeries/procedures (MIS) is on the rise as these surgeries have a success rate of around 90%. These procedures result in less trauma for the patient and quicker recovery than invasive procedures. Another reason for this change is the risk of infection associated with invasive surgeries. Atherectomy is a minimally invasive procedure; therefore, the rising demand for minimally invasive surgeries is expected to render a high-impact driver for the market during the forecast period.

Traditionally, open surgery has been used to address plaque buildup, which is invasive, hazardous, and takes a long time to recover from. However, atherectomy devices have enabled doctors to perform fewer invasive treatments that lead to shorter recovery times and a lower risk of complications. In addition, atherectomy devices have the potential to increase drug efficacy by evaluating the use of orbital atherectomy to treat CAD in patients who are not eligible for Coronary Artery Bypass (CAB) grafting and evaluating the use of rotational atherectomy to treat PAD in patients who are not eligible for Endovascular Therapy (EVT). The results of these clinical trials are expected to further demonstrate the potential of atherectomy devices and could lead to their wider adoption in the treatment of cardiovascular diseases.

Analyst Perspective

The atherectomy devices market is expected to witness steady growth in the coming years, driven by the rising prevalence of peripheral artery disease, the increasing incidence of calcified vascular lesions, and the growing adoption of minimally invasive endovascular procedures. Technological advancements in rotational, orbital, directional, and laser atherectomy systems are improving procedural efficiency and expanding clinical applications. North America is expected to remain a key market, while the Asia Pacific is likely to experience faster growth due to improving healthcare infrastructure and procedure volumes. However, competition from intravascular lithotripsy and pricing pressures may moderate market expansion over the forecast period.

Market Dynamics

Regional Insights

North America atherectomy devices market dominated the global market in 2025, accounting for around 40.0% of the global revenue in 2025. The region’s dominance is attributed to the presence of advanced healthcare infrastructure, favorable reimbursement conditions, a high prevalence of PAD and cardiovascular diseases, and broad availability of FDA-cleared atherectomy technologies. The region also benefits from high procedural volumes, a well-established network of vascular intervention centers, and strong adoption of minimally invasive endovascular procedures. Continued investments in innovative plaque-modification technologies and increasing use of atherectomy for complex and calcified lesions are expected to sustain regional market growth.

To learn more about this report, Download Free Sample Report

Asia Pacific Atherectomy Devices Market Trends

Asia Pacific is expected to register the fastest CAGR during the forecast period from 2026 to 2033. The growth is driven by the rising burden of PAD and other cardiovascular diseases, population aging, improving healthcare infrastructure, and increasing adoption of minimally invasive vascular interventions. Expanding access to advanced medical devices, growing healthcare expenditure, and increasing investments by global medical device manufacturers are further supporting market expansion. For instance, in February 2025, China's National Medical Products Administration (NMPA) approved Boston Scientific's JETSTREAM PVCN100 Console and JETSTREAM Over-the-Wire Atherectomy Catheter for marketing, expanding access to advanced plaque-excision technology for femoropopliteal disease in China.

Europe Atherectomy Devices Market Trends

Europe is expected to maintain a significant share of the atherectomy devices market during the forecast period, supported by the region's aging population, high burden of cardiovascular and peripheral vascular diseases, and well-developed healthcare infrastructure. Increasing adoption of minimally invasive endovascular procedures, rising awareness of advanced PAD treatment options, and the availability of sophisticated vascular intervention technologies are contributing to regional growth. In addition, favorable healthcare policies, established reimbursement systems in major European markets, and continued investments in medical device innovation are expected to support the adoption of atherectomy technologies, particularly for the treatment of complex and heavily calcified lesions.

Key Atherectomy Devices Company Insights

Market participants are focusing on product development, clinical evidence generation, regulatory approvals, strategic collaborations, and geographic expansion to strengthen their positions in the global atherectomy devices market. The competitive landscape includes established medical device companies with broad vascular intervention portfolios as well as specialized manufacturers focused on atherectomy technologies.

Key Atherectomy Devices Companies

The following key companies have been profiled for this study on the atherectomy devices market.

• Abbott

• Avinger

• BD

• Boston Scientific Corporation

• Cardiovascular Systems, Inc.

• Cordis

• Koninklijke Philips N.V.

• Medtronic

• Terumo Medical Corporation

Recent Development

• In October 2025, BD announced the enrollment of the first patient in the XTRACT Registry for its Rotarex Catheter System. The post-market study is designed to collect real-world evidence on the performance of Rotarex in treating peripheral artery disease lesions and support clinical decision-making and treatment optimization.
• In May 2025, BD announced plans to initiate the XTRACT prospective, multicenter post-market registry to evaluate real-world outcomes associated with its Rotarex Atherectomy System in patients with peripheral artery disease. The registry is expected to enroll up to 600 patients across approximately 100 U.S. clinical sites, generating additional evidence on the safety and effectiveness of the system in peripheral vascular interventions
• In January 2025, AngioDynamics initiated the AMBITION BTK randomized controlled trial and registry to evaluate the Auryon Atherectomy System in combination with standard balloon angioplasty for below-the-knee peripheral artery disease lesions in patients with critical limb ischemia. The study is expected to generate additional clinical evidence supporting the use of laser atherectomy in complex and calcified lesions, strengthening the company's position in the peripheral atherectomy market

Global Atherectomy Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global atherectomy devices market based on type and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Directional Atherectomy

  • Rotational Atherectomy

  • Orbital Atherectomy

  • Laser Atherectomy

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait